Gene · 6876
Papers4,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Linc-ROR Modulates the Endothelial-Mesenchymal Transition of Endothelial Progenitor Cells through the miR-145/Smad3 Signaling Pathway. | Physiol Res | 2024 | 39264078 | PubTator, text mining | PubMed |
| [Involvement of microRNA-145/TGF-β in the regulation of swimming exercise on vascular calcification in type 2 diabetic rats]. | Sheng Li Xue Bao | 2024 | 39192786 | PubTator, text mining | PubMed |
| CircLMBR1 inhibits phenotypic transformation of hypoxia-induced pulmonary artery smooth muscle via the splicing factor PUF60. | Eur J Pharmacol | 2024 | 39059570 | PubTator, text mining | PubMed |
| Enhanced expression of miR-20a driven by nanog exacerbated the degradation of extracellular matrix in thoracic aortic dissection. | Noncoding RNA Res | 2024 | 39022686 | PubTator, text mining | PubMed |
| Comparative single-cell transcriptional and proteomic atlas of clinical-grade injectable mesenchymal source tissues. | Sci Adv | 2024 | 38996032 | PubTator, text mining | PubMed |
| L-Wnk1 Deletion in Smooth Muscle Cells Causes Aortitis and Inflammatory Shift. | Circ Res | 2024 | 38979610 | PubTator, text mining | PubMed |
| LPS-induced senescence of macrophages aggravates calcification and senescence of vascular smooth muscle cells via IFITM3. | Ren Fail | 2024 | 38973391 | PubTator, text mining | PubMed |
| TGFβ1 Regulates Cellular Composition of In Vitro Cardiac Perivascular Niche Based on Cardiospheres. | Bull Exp Biol Med | 2024 | 38963596 | PubTator, text mining | PubMed |
| miR-200a-3p-enriched MSC-derived extracellular vesicles reverse erectile function in diabetic rats by targeting Keap1. | Biomed Pharmacother | 2024 | 38959607 | PubTator, text mining | PubMed |
| The Expression of a Subset of Aging and Antiaging Markers Following the Chondrogenic and Osteogenic Differentiation of Mesenchymal Stem Cells of Placental Origin. | Cells | 2024 | 38920652 | PubTator, text mining | PubMed |
| Basal ATP release signals through the P2Y2 receptor to maintain the differentiated phenotype of vascular smooth muscle cells. | Atherosclerosis | 2024 | 38889566 | PubTator, text mining | PubMed |
| In vitro and in vivo Evaluation of Antifibrotic Properties of Verteporfin in a Composition of a Collagen Scaffold. | Biochemistry (Mosc) | 2024 | 38880654 | PubTator, text mining | PubMed |
| Activin A Is a Master Regulator of Phenotypic Switch in Adipose Stromal Cells Initiated by Activated Immune Cell-Secreted Interleukin-1β. | Stem Cells Dev | 2024 | 38877807 | PubTator, text mining | PubMed |
| 2‑D08 mediates notable anticancer effects through multiple cellular pathways in uterine leiomyosarcoma cells. | Oncol Rep | 2024 | 38874019 | PubTator, text mining | PubMed |
| Low-intensity pulsed ultrasound combined with ST36 modulate gastric smooth muscle contractile marker expression via RhoA/Rock and MALAT1/miR-449a/DLL1 signaling in diabetic rats. | Neurogastroenterol Motil | 2024 | 38873849 | PubTator, text mining | PubMed |
| Progenitor-like cells contributing to cellular heterogeneity in the nucleus pulposus are lost in intervertebral disc degeneration. | Cell Rep | 2024 | 38865240 | PubTator, text mining | PubMed |
| CD163+ Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma. | Circ Res | 2024 | 38860377 | PubTator, text mining | PubMed |
| Bioengineering methods for vascularizing organoids. | Cell Rep Methods | 2024 | 38759654 | PubTator, text mining | PubMed |
| The Mechanism and Function of circlRP6 Targeting miR-145 in Occurrence of Intracranial Aneurysms. | Altern Ther Health Med | 2024 | 38743893 | PubTator, text mining | PubMed |
| N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension. | Cell Mol Biol Lett | 2024 | 38741032 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6876/papers?page=13